Allergan Inc.
2525 Dupont Drive
Irvine,
CA 92612
United States - Map
Phone: 714-246-4500
Fax: 714-246-6987
Web Site: http://www.allergan.com
| Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, and allergy; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the Lap-Band System and the BIB BioEnterics Intragastric Balloon; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David E.I. Pyott , 55
Chairman and Chief Exec. Officer |
$
2.56M |
$
0 | Mr. Michael Ball , 51
Pres |
$
1.01M |
$
0 | Mr. Gavin S. Herbert , 76
Founder, Chairman Emeritus and Member of Science & Technology Committee |
$
57.00K | N/A | Mr. Jeffrey L. Edwards , 48
Chief Financial Officer and Exec. VP of Fin. & Bus. Devel. |
$
759.00K |
$
0 | Mr. Douglas S. Ingram J.D., Esq., 46
Chief Admin. Officer, Chief Ethics Officer, Exec. VP, Gen. Counsel and Sec. |
$
828.00K |
$
521.00K |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.34% Nasdaq 0.00%
Profile
